In article number 2309705 by Luisa Torsi and co-workers, CRISPR strip tests and SiMoT bioelectronic devices, are reviewed as highly effective point-of-care technologies.They possess the unique capability to assay single molecules at concentrations of 10 -20 molar, coupled with exceptional reliability, demonstrating diagnostic sensitivity and selectivity exceeding 95-99%.An androgynous humanoid is holding the palmar device, which can be used in a wide range of One Health applications.
No takes yet. Share an insight, caveat, or question.
Macchia et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Advanced Materials